BIOGEN revenue for the last year amounted to 8.91 B EUR, the most of which — 8.91 B EUR — came from its highest performing source at the moment, Innovative Therapies, the year earlier bringing 9.51 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought BIOGEN 4.92 B EUR, and the year before that — 5.17 B EUR.